"Programs offered at John and Dorothy Morgan Cancer Center include clinical trials, a variety of psychosocial supportive care and outreach programs, and home care and hospice services. Oncology-related education and training opportunities for health care professionals are also provided."

During the past decade, Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 56 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 48 trials, followed by "SWOG Cancer Research Network" with 10 trials sponsored, "NSABP Foundation Inc" with 9 trials sponsored, "Eastern Cooperative Oncology Group" with 8 trials sponsored and "Gynecologic Oncology Group" with 8 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest" #1 collaborator was "National Cancer Institute (NCI)" with 95 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "North Central Cancer Treatment Group" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "Eastern Cooperative Oncology Group" with 4 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest" are "Breast Cancer" (24 trials), "Lung Cancer" (16 trials), "Colorectal Cancer" (8 trials), "Melanoma (Skin)" (8 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (8 trials). Many other conditions were trialed in "Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest" in a lesser frequency.

Most popular intervention types in "Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest" are "Drug" (81 trials), "Biological" (30 trials), "Radiation" (25 trials), "Other" (23 trials) and "Procedure" (17 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (16 trials), "radiation therapy" (15 trials), "bevacizumab" (12 trials), "carboplatin" (12 trials) and "paclitaxel" (10 trials). Other intervention names were less common.

The vast majority of trials in "Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest" are 67 trials for "All" genders, 28 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 87 completed trials in Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest, 3 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".